This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

Aptose Biosciences, Inc.
11/10/2020
Thank you. Good afternoon. My name is Chris, and I'll be your conference operator today. I would like to welcome everyone to Apto's Biosciences conference call for the third quarter ended September 30, 2020. At this time, all participants are in a listen-only mode. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypad. If you would like to withdraw your question, please press the pound key. Thank you. And as a reminder, this conference call may be recorded. I would now like to introduce Ms. Susan Pietropaolo. Please go ahead.
Thank you, Chris. Good afternoon and welcome to the Aptos Biosciences Conference Call to discuss financial and operational results for the third quarter ended September 30th, 2020. I am Susan Pietropalo, a communications representative for Aptos Biosciences. Joining me on the call today are Dr. William G. Rice, chairman, president, and CEO, Mr. Gregory Chow, executive vice president and chief financial officer, Dr. Yodi Morongo, senior vice president and chief business officer, Dr. Rafael Behar, senior vice president and chief medical officer, Do you all hear that?
No, we can hear you.
You're reading a preview of the APTO Q3 2020 earnings call.
Free account.